Francesco Ciccarese

VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells

Matteo Curtarello, Elisabetta Zulato, Giorgia Nardo et al. · Cancer Research · 2014 · 70 citations · Full text

Tumor Metabolism, Oncology, Angiogenesis +14

Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells

Francesco Ciccarese, Vittoria Raimondi, Evgeniya Sharova et al. · Antioxidants · 2020 · 62 citations · Full text

Nanoparticles, Nanomedicine, Tumor Biology +13

The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study

Alessandro Vitale, Fabio Farinati, Timothy M. Pawlik et al. · Liver International · 2019 · 59 citations · Full text

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab

Laura Bonanno, Angela De Paoli, Elisabetta Zulato et al. · Clinical Cancer Research · 2017 · 53 citations · Full text

LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation

Elisabetta Zulato, Francesco Ciccarese, Valentina Agnusdei et al. · Biochemical Pharmacology · 2018 · 41 citations

Redox Signaling, Lkb1 Loss, Medicine +9